Hwang CK, Wagley Y, Law P-Y, Wei L-N, Loh HH (2012) MicroRNAs in opioid pharmacology. J Neuroimmune Pharmacol. doi:10.1007/s11481-011-9323-2
Karmaus PWF, Chen W, Kaplan BLF, Kaminski NE (2012) Δ9-Tetrahydrocannabinol suppresses cytotoxic t lymphocyte function independent of CB1 and CB2, disrupting early activation events. J Neuroimmune Pharmacol. doi:10.1007/s11481-011-9293-4
Mithal DS, Banisadr G, Miller RJ (2012) CXCL12 Signaling in the development of the nervous system. J Neuroimmune Pharmacol. doi:10.1007/s11481-011-9336-x
Panas MW, Xie Z, Panas HN, Hoener MC, Vallender EJ, Miller GM (2011) Trace amine associated receptor 1 signaling in activated lymphocytes. J Neuroimmune Pharmacol. doi:10.1007/s11481-011-9321-4
Podhaizer EM, Zou S , Fitting S, Samano KL, El-Hage N, Knapp PE, Hauser KF (2011) Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J Neuroimmune Pharmacol. doi:10.1007/s11481-011-9326-z
Sharir H, Console-Bram L, Mundy C, Popoff SN, Kapur A, Abood ME (2012) The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55. J Neuroimmune Pharmacol. doi:10.1007/s11481-012-9351-6
Zhang L, Belkowski JS, Briscoe T, Rogers TJ (2012) Regulation of Mu opioid receptor expression in developing T cells. J Neuroimmune Pharmacol (in this issue)